Quell 2.0

NeuroMetrix pivoting from D2C, restructuring business following weak performance of Quell pain relief wearable
By Dave Muoio | 03:22 pm | August 09, 2019
The company laid off more than half of its staff since the beginning of 2019.
Theranos set to dissolve, Chinese online pharmacy scores $130M, and more digital health news briefs
By MobiHealthNews | 05:06 pm | September 05, 2018
Also: Cricket Health raises $24 million, and NeuroMetrix releases Quell 2.0.